The AMWAY ONE BY ONE® Campaign for Children is marking its 10th anniversary with a remarkable accomplishment – helping 10 million children live better lives.
Amway has been committed to providing people around the globe with hope and opportunity for more than five decades. In 2003, Amway chose to focus its charitable efforts on the single global social cause of helping children live better lives by harnessing the power of interpersonal and business relationships made possible by Amway distributors and employees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55864-amway-one-by-one-campaign-for-children-10th-anniversary
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Matthew Schultz drops exciting and hot new single Crazy Heart (feat. Alessia Guarnera) available on iTunes now https://itunes.apple.com/us/album/crazy-heart-feat.-alessia/id872735912 make sure you get a copy today.
Supergoop!® announces its partnership with entrepreneur and international tennis sensation Maria Sharapova, welcoming her to the Supergoop! team as a co-owner with Founder and CEO Holly Thaggard. Supergoop! is the first and only multi-functional skincare line in prestige distribution with a foundation in UV protection and 100% dedication to sun safety. This partnership will be a vehicle for Supergoop! to spotlight the brand’s mission to elevate skin cancer awareness alongside the many skincare and beauty benefits attributed to applying UV protection every single day.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7190451-supergoop-partnership-tennis-maria-sharapova-sun-protection-skincare
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Snaptron offer Tactile metal dome placement tool that ensures single dome placement in membrane applications. For more detail about this visit our website http://www.snaptron.com/
Subaru of America, Inc. (SOA) has reported record sales of 513,693 vehicles for the 2014 calendar year. This is an increase of 21 percent over the previous record of 424,683 vehicles, which was set in 2013. This sixth consecutive record also represents the largest ever single–year increase in volume for the brand.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7074156-subaru-reports-record-sales-2014/
Michelin today marked the opening of its newest plant in North America, which will produce the innovative MICHELIN® X® TWEEL® Airless Radial Tire™ for commercial applications.
An idea first conceived by Michelin research engineers in the United States, the TWEEL is a revolutionary non-pneumatic tire that changed the configuration of a conventional tire, bringing together the tire and the wheel assembly into one solid unit. The TWEEL comprises a rigid hub connected to a shear beam by means of flexible, deformable polyurethane spokes, all functioning as a single unit.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7381451-michelin-open-s-first-manufacturing-plant-tweel-airless-radial-tire/
